Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 380

1.

Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.

Butler GK, Montgomery AM.

Drug Alcohol Depend. 2004 Oct 5;76(1):55-62.

PMID:
15380289
2.

Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.

Parrott AC, Sisk E, Turner JJ.

Drug Alcohol Depend. 2000 Jul 1;60(1):105-10.

PMID:
10821995
3.

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.

Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J.

Addict Behav. 2004 Jun;29(4):743-52.

PMID:
15135556
4.
5.

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

Morgan MJ, McFie L, Fleetwood H, Robinson JA.

Psychopharmacology (Berl). 2002 Jan;159(3):294-303. Epub 2001 Oct 12.

PMID:
11862362
6.

Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.

Allott K, Canny BK, Broadbear JH, Stepto NK, Murphy B, Redman J.

J Psychopharmacol. 2009 Sep;23(7):759-74. doi: 10.1177/0269881108092336. Epub 2008 Jun 18.

PMID:
18562414
7.

Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.

Soar K, Parrott A, Turner J.

J Psychopharmacol. 2009 Sep;23(7):745-58. doi: 10.1177/0269881108092594. Epub 2008 Jul 17.

PMID:
18635698
8.

Memory deficits associated with recreational use of "ecstasy" (MDMA).

Morgan MJ.

Psychopharmacology (Berl). 1999 Jan;141(1):30-6.

PMID:
9952062
9.

Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.

de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.

J Psychopharmacol. 2008 Jul;22(5):498-510. doi: 10.1177/0269881107081545. Epub 2008 Jan 21.

PMID:
18208910
10.

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

Morgan MJ.

Neuropsychopharmacology. 1998 Oct;19(4):252-64.

11.

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.

Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E.

Psychopharmacology (Berl). 2004 May;173(3-4):398-404. Epub 2004 Jan 14.

PMID:
14722704
12.

Enhanced intensity dependence and aggression history indicate previous regular ecstasy use in abstinent polydrug users.

Wan L, Baldridge RM, Colby AM, Stanford MS.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1484-90. doi: 10.1016/j.pnpbp.2009.08.007. Epub 2009 Aug 22.

PMID:
19703509
13.

Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).

Taurah L, Chandler C, Sanders G.

Psychopharmacology (Berl). 2014 Feb;231(4):737-51. doi: 10.1007/s00213-013-3288-1. Epub 2013 Oct 11.

PMID:
24114426
14.

Impulsivity, inhibition and negative priming in ecstasy users.

Dafters RI.

Addict Behav. 2006 Aug;31(8):1436-41. Epub 2005 Oct 19.

PMID:
16242244
15.

Alcohol use and risk taking among regular ecstasy users.

Breen C, Degenhardt L, Kinner S, Bruno R, Jenkinson R, Matthews A, Newman J.

Subst Use Misuse. 2006;41(8):1095-109.

PMID:
16798678
16.

Everyday memory deficits in ecstasy-polydrug users.

Montgomery C, Fisk JE.

J Psychopharmacol. 2007 Sep;21(7):709-17. Epub 2007 Jul 2.

PMID:
17606476
17.

Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.

Bedi G, Van Dam NT, Redman J.

J Psychopharmacol. 2010 Feb;24(2):233-40. doi: 10.1177/0269881108097631. Epub 2008 Oct 2.

PMID:
18832429
18.

Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.

Morgan MJ, Impallomeni LC, Pirona A, Rogers RD.

Neuropsychopharmacology. 2006 Jul;31(7):1562-73. Epub 2005 Nov 9.

19.

Is emotional intelligence impaired in ecstasy-polydrug users?

Craig L, Fisk JE, Montgomery C, Murphy PN, Wareing M.

J Psychopharmacol. 2010 Feb;24(2):221-31. doi: 10.1177/0269881108095713. Epub 2008 Sep 18.

PMID:
18801831
20.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.

J Psychopharmacol. 2006 Mar;20(2):211-25. Review.

PMID:
16510479

Supplemental Content

Support Center